150 related articles for article (PubMed ID: 2507221)
21. Fluoroquinolone (Lomefloxacin) International Surveillance Trial: a report of 30 months of monitoring in vitro activity.
Jones RN
Am J Med; 1992 Apr; 92(4A):52S-57S. PubMed ID: 1316072
[TBL] [Abstract][Full Text] [Related]
22. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae.
Rossolini GM; Valentini S; Vaiani G; Satta G
J Chemother; 1989 Jul; 1(4 Suppl):173-6. PubMed ID: 16312356
[No Abstract] [Full Text] [Related]
23. A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents.
Markowitz SM; Williams DS; Hanna CB; Parker JL; Pierce MA; Steele JC
Chemotherapy; 1995; 41(6):477-86. PubMed ID: 8529440
[TBL] [Abstract][Full Text] [Related]
24. Antibacterial activity of the new quinolone CI-960 (PD 127391) against clinical isolates at a major tertiary care center in Saudi Arabia.
Qadri SM; Abo-Askar H; Ueno Y
Chemotherapy; 1992; 38(2):92-8. PubMed ID: 1317281
[TBL] [Abstract][Full Text] [Related]
25. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of lomefloxacin.
Piddock LJ; Hall MC; Wise R
Antimicrob Agents Chemother; 1990 Jun; 34(6):1088-93. PubMed ID: 2168142
[TBL] [Abstract][Full Text] [Related]
27. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Jones RN; Aldridge KE; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA; Washington JA
Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151
[TBL] [Abstract][Full Text] [Related]
28. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
29. In vitro antibacterial activity of Q-35, a new fluoroquinolone.
Ito T; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1992 Aug; 36(8):1708-14. PubMed ID: 1329626
[TBL] [Abstract][Full Text] [Related]
30. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
31. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of lomefloxacin as compared with ciprofloxacin.
Inderlied CB; Lancero MG; Bermudez LM; Young LS
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):17S-20S. PubMed ID: 2791493
[TBL] [Abstract][Full Text] [Related]
33. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
[TBL] [Abstract][Full Text] [Related]
34. Lomefloxacin activity against 2,813 clinical isolates: a collaborative study at three medical centers in Brazil.
Magalhaes M; Trabulsi LR; Montelli AC
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):35S-39S. PubMed ID: 2791496
[TBL] [Abstract][Full Text] [Related]
35. Lomefloxacin: microbiologic assessment and unique properties.
Mayer KH; Ellal JA
Am J Med; 1992 Apr; 92(4A):58S-62S. PubMed ID: 1316073
[TBL] [Abstract][Full Text] [Related]
36. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
Sun ZM; Maskell JP; Sehgal SC; Williams JD
Infection; 1989; 17(3):165-7. PubMed ID: 2737760
[TBL] [Abstract][Full Text] [Related]
37. Comparative in vitro activity of lomefloxacin, a new difluoroquinolone.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):164-8. PubMed ID: 2498101
[TBL] [Abstract][Full Text] [Related]
38. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Morel C; Acar JF; Thabaut A; Fleurette J; Vallée E; Dabernat H; Chanal M; Drugeon H
Pathol Biol (Paris); 1990 May; 38(5):390-6. PubMed ID: 2195448
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
Wise R; Andrews JM; Ashby JP; Matthews RS
Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial effects of lomefloxacin in vitro.
Chambers ST; Peddie BA; Robson RA; Begg EJ; Boswell DR
J Antimicrob Chemother; 1991 Apr; 27(4):481-9. PubMed ID: 1856127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
